131 related articles for article (PubMed ID: 31828783)
1. A novel
Famulari G; Duclos M; Enger SA
Med Phys; 2020 Mar; 47(3):859-868. PubMed ID: 31828783
[TBL] [Abstract][Full Text] [Related]
2. A novel minimally invasive dynamic-shield, intensity-modulated brachytherapy system for the treatment of cervical cancer.
Morcos M; Antaki M; Viswanathan AN; Enger SA
Med Phys; 2021 Jan; 48(1):71-79. PubMed ID: 32916763
[TBL] [Abstract][Full Text] [Related]
3. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
[TBL] [Abstract][Full Text] [Related]
4. Interstitial rotating shield brachytherapy for prostate cancer.
Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
[TBL] [Abstract][Full Text] [Related]
5. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
[TBL] [Abstract][Full Text] [Related]
6. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
[TBL] [Abstract][Full Text] [Related]
7. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry study of novel rotating MRI-compatible shielded tandems for intensity modulated cervix brachytherapy.
Morcos M; Enger SA
Phys Med; 2020 Mar; 71():178-184. PubMed ID: 32163887
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Rotating Shield Brachytherapy for Prostate Cancer Dose Escalation and Urethral Sparing.
Adams Q; Hopfensperger KM; Kim Y; Wu X; Xu W; Shukla H; McGee J; Caster JM; Flynn RT
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1543-1550. PubMed ID: 30092333
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo dosimetric characterization of a new high dose rate
Famulari G; Linares Rosales HM; Dupere J; Medich DC; Beaulieu L; Enger SA
Med Phys; 2020 Sep; 47(9):4563-4573. PubMed ID: 32686145
[TBL] [Abstract][Full Text] [Related]
11. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
[TBL] [Abstract][Full Text] [Related]
12. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate.
Kunogi H; Cunha JAM; Chang AJ; Gadzinski AJ; Shinohara K; Hsu IC
Brachytherapy; 2017; 16(6):1113-1118. PubMed ID: 28869143
[TBL] [Abstract][Full Text] [Related]
13. Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer.
Dadkhah H; Hopfensperger KM; Kim Y; Wu X; Flynn RT
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):719-728. PubMed ID: 28843372
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo calculation of the dose perturbations in a dual-source HDR/PDR afterloader treatment unit.
Collins-Fekete CA; Plamondon M; Verhaegen F; Beaulieu L
Brachytherapy; 2016; 15(4):524-530. PubMed ID: 27317950
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry modeling for focal high-dose-rate prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Thwaites D; Henry A
Brachytherapy; 2014; 13(6):611-7. PubMed ID: 25085456
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review of Intensity-Modulated Brachytherapy (IMBT): Static and Dynamic Techniques.
Callaghan CM; Adams Q; Flynn RT; Wu X; Xu W; Kim Y
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):206-221. PubMed ID: 31026556
[TBL] [Abstract][Full Text] [Related]
17. Three dimensional intensity modulated brachytherapy (IMBT): dosimetry algorithm and inverse treatment planning.
Shi C; Guo B; Cheng CY; Esquivel C; Eng T; Papanikolaou N
Med Phys; 2010 Jul; 37(7):3725-37. PubMed ID: 20831080
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.
Major T; Polgár C; Jorgo K; Stelczer G; Ágoston P
Brachytherapy; 2017; 16(3):608-615. PubMed ID: 28325472
[TBL] [Abstract][Full Text] [Related]
19. The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy.
Smith RL; Panettieri V; Lancaster C; Mason N; Franich RD; Millar JL
Australas Phys Eng Sci Med; 2015 Mar; 38(1):55-61. PubMed ID: 25481387
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.
Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Polgár C; Major T
Strahlenther Onkol; 2010 Jul; 186(7):388-95. PubMed ID: 20582396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]